FDAFDA recall D-0038-2027 · Oct 21, 2026
Teva Pharmaceuticals USA, Inc: Metoclopramide Tablets recall
Recall found
Product
Metoclopramide Tablets, USP, 5 mg, [100 or 500] Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC 100 Tablets: 0093-2204-01; NDC 500 Tablets: 0093-2204-05
Reason for recall
Presence of Foreign Tablets/Capsules
What to do
FDA enforcement reports don't include consumer instructions. Check the codes below against your packaging. If this is a medicine or device you use, talk to your pharmacist or doctor before you stop or change anything, and contact the company or FDA for what to do with the product.
Recall details
- FDA classification
- Class II: use of or exposure to the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
- Status
- Ongoing
- Codes, lots and dates
- Lot, expiry: [100 Tablets] Lots 8634085, 8635085, 8636085, exp 07/2027; [500 Tablets] Lot 8633085, exp 07/2027
- Quantity
- 240,448 cartons
- Distribution
- US Nationwide.
- Recalling firm
- Teva Pharmaceuticals USA, Inc, Parsippany, NJ
- Voluntary or mandated
- Voluntary: Firm initiated
- Recall started
- 2026-09-29
Source: openFDA enforcement record D-0038-2027 · search recall number D-0038-2027 in FDA's Enforcement Report.
Copied from the agency record without changes. Data as of Oct 26, 2026, 8:14 PM EDT. The agency notice is the final word.